UAS Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

UAS Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-5,000	Closed	-$385K	–	15
2022 Q2	$385K	Buy	+5,000	New	+$381K	0.11%	19
2019 Q1	–	Sell	-17,750	Closed	-$923K	–	25
2018 Q4	$923K	Buy	+17,750	New	+$954K	0.63%	11
2018 Q2	–	Sell	-3,500	Closed	-$221K	–	25
2018 Q1	$221K	Sell	3,500 -16,500	-83%	-$1.06M	0.11%	30
2017 Q4	$1.23M	Buy	+20,000	New	+$1.25M	0.57%	18
2017 Q2	–	Sell	-156,855	Closed	-$8.53M	–	29
2017 Q1	$8.53M	Buy	156,855 +70,925	+83%	+$3.89M	4.91%	7
2016 Q4	$5.02M	Sell	85,930 -63,200	-42%	-$3.46M	2.97%	13
2016 Q3	$8.04M	Buy	149,130 +77,050	+107%	+$4.95M	5.52%	7
2016 Q2	$5.3M	Sell	72,080 -1,550	-2%	-$110K	3.07%	11
2016 Q1	$4.7M	Sell	73,630 -675	-0.9%	-$42.6K	2.78%	11
2015 Q4	$5.11M	Sell	74,305 -40	-0.1%	-$2.64K	3.27%	10
2015 Q3	$4.4M	Sell	74,345 -143,365	-66%	-$9.09M	2.97%	11
2015 Q2	$14.5M	Sell	217,710 -1,415	-0.6%	-$93.3K	7.54%	5
2015 Q1	$14.1M	Buy	219,125 +8,875	+4%	+$556K	7.56%	5
2014 Q4	$12.4M	Sell	210,250 -885	-0.4%	-$49.9K	6.63%	6
2014 Q3	$10.8M	Sell	211,135 -34,300	-14%	-$1.71M	6.17%	8
2014 Q2	$11.9M	Buy	245,435 +18,450	+8%	+$909K	6.62%	7
2014 Q1	$11.8M	Sell	226,985 -11,505	-5%	-$612K	7.02%	5
2013 Q4	$12.7M	Sell	238,490 -1,975	-0.8%	-$101K	7.67%	4
2013 Q3	$11.1M	Buy	240,465 +2,850	+1%	+$125K	7.64%	4
2013 Q2	$10.6M	Buy	+237,615	New	+$10.3M	7.4%	6

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UAS Asset Management's BMY Position: Q3 2022 in Review

UAS Asset Management sold out of Bristol-Myers Squibb (BMY) in Q3 2022, closing a stake of 5,000 shares — an estimated $385K sold.

UAS Asset Management first reported a position in BMY in Q2 2013 and held it in 20 quarters. The position peaked at $14.5M in Q2 2015. 2,469 funds tracked by Wall St. Rank hold BMY as of Q3 2022.

UAS Asset Management reported no remaining Bristol-Myers Squibb position as of Q3 2022 after selling out during the quarter.
UAS Asset Management sold 5,000 Bristol-Myers Squibb shares in Q3 2022, an estimated $385K.
UAS Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 20 quarters.
UAS Asset Management's Bristol-Myers Squibb position peaked at $14.5M in Q2 2015.
2,469 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.

Based on UAS Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.